ALEMBICLTDNSEAlembic Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 27 Jun · 20:31 IST

Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Chirayu Amin, a promoter of Alembic Limited, along with 33 persons acting in concert (including Nirayu Limited, Shreno Limited, Alembic Pharmaceuticals, Paushak Limited, and various family members and trusts), has filed an annual declaration with BSE and NSE confirming that no encumbrance (such as pledge or lien) was created on the company's shares during financial year 2024-25. This is a routine SEBI-mandated filing under Regulation 31(4) of the Takeover Regulations. The declaration covers the full promoter group, including listed group entities, family members, HUFs, trusts, and LLPs.

Likely market impact

This is a neutral to mildly positive disclosure for shareholders — it confirms promoters have not pledged additional shares as collateral, reducing near-term concerns about forced selling or margin calls. No impact on stock price is expected as this is a standard annual compliance filing.